Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells.

Han, X

Tissue inhibitor of metalloproteinase-1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. [electronic resource] - Diabetes May 2001 - 1047-55 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0012-1797

10.2337/diabetes.50.5.1047 doi


Animals
Apoptosis--drug effects
Cell Survival--drug effects
Cells, Cultured
Cytokines--antagonists & inhibitors
DNA Fragmentation--drug effects
Flow Cytometry
Gene Expression Regulation, Enzymologic--drug effects
Genes, Reporter
Glucose--pharmacology
In Vitro Techniques
Insulin--metabolism
Insulin Secretion
Interferon-gamma--toxicity
Interleukin-1--toxicity
Islets of Langerhans--cytology
Luciferases--genetics
Mice
NF-kappa B--genetics
Nitric Oxide Synthase--genetics
Nitric Oxide Synthase Type II
Rats
Recombinant Proteins--metabolism
Tissue Inhibitor of Metalloproteinase-1--genetics
Tissue Inhibitor of Metalloproteinase-2--pharmacology
Transfection
Tumor Necrosis Factor-alpha--pharmacology